Skip to Main Content

Paper Details

CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphoma.
Leukemia
4
2023
Author NameAffiliation
Frank P DiFilippoImaging Institute, Cleveland Clinic
  • 1 - 1

Datasets

Release 1.2